In Brief

MedlinePlus highlights both the benefits and risks of acetaminophen, a widely used pain reliever, stressing proper dosage to avoid liver damage.

Key Points

  • Acetaminophen is widely used for pain and fever relief.
  • Safe at recommended doses but can cause severe liver damage if overused.
  • Many multi-symptom medications also contain acetaminophen, raising overdose risk.
  • MedlinePlus urges patients to check labels and consult doctors when in doubt.

WASHINGTON, D.C., September 23– Acetaminophen, one of the most common over-the-counter medications for pain and fever, is back in the spotlight as MedlinePlus releases updated guidance on its safe use.

Health experts emphasize that while acetaminophen—also known as paracetamol—is considered safe when taken as directed, exceeding the recommended dose can have serious consequences.

“When taken within the guidelines, acetaminophen is safe and effective for headaches, colds, arthritis, and flu-like symptoms,” MedlinePlus states. “But taking too much can lead to severe liver damage, sometimes requiring a transplant.”

Background and Concerns

Acetaminophen is trusted by millions for its fast relief of fever and mild to moderate pain. However, it is also one of the leading causes of drug-related liver injury in the United States. According to medical professionals, many overdoses occur unintentionally when people combine multiple medications containing acetaminophen.

Pharmacists are urging the public to read labels carefully. “It’s not uncommon for cold, flu, and pain medications to contain acetaminophen as an ingredient,” explained Dr. Laura Sanders, a clinical pharmacist. “That’s where people get into trouble—stacking doses without realizing it.”

Next Steps

Authorities are calling for increased awareness. Public health campaigns are expected to roll out this fall, focusing on proper dosage instructions and safe storage. Experts encourage patients to consult their healthcare provider if they are unsure about how much is safe.

Advertisement

Comments

No comments yet. Be the first to comment!